Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Pfizer Increases Warning on Bextra Skin Risk Pfizer Inc. on Friday said two clinical trials showed patients taking its anti-inflammatory drug Bextra had a higher risk of cardiovascular events during high-risk coronary bypass surgery.
